Active Ingredient: RALOXIFENE HYDROCHLORIDE
Proprietary Name: RALOXIFENE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 60MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A211324
Product Number: 001
Approval Date: Aug 18, 2020
Applicant Holder Full Name: CADILA PHARMACEUTICALS LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
